Form 4 for DGX Quest Diagnostics
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001955265-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,586 | 9,116 | +21% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $208.41 | -435 | 8,911 | -5% | -$90.7K |
| D | 2026-02-20 | 2026-01-28 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $183.51 | +15 | 8,696 | +0.2% | +$2,753 |
| D | 2026-02-20 | 2026-02-18 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +7,332 | 7,332 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | A | A | 1,586 | $0.00 | 9,116 | D | — | — | (F1) Represents an award of restricted stock units. |
| 2 | Common | Common Stock | 2026-02-18 | F | D | 230 | $206.99 | 8,681 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-02-18 | F | D | 205 | $210.01 | 8,911 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 4 | Common | Common Stock | 2026-01-28 | L | A | 15 | $183.51 | 8,696 | D | — | — | (F3) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2026-02-18 | A | A | 7,332 | $0.00 | 7,332 | D | $204.96 · — to 2036-02-18 | 7,332 Common Stock | (F4) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |